Advances in neuro-technology are accelerating at an astounding pace, and at times seem closer to science fiction than science fact. Let’s peer into the crystal ball and look ahead at the major...
QMENTA News
Cloud AI Medical Imaging Expert QMENTA, Inc. Announces FDA 510(k) Clearance of Platform at RSNA 2021
Cloud AI Medical Imaging Expert QMENTA, Inc. Announces FDA 510(k) Clearance of Platform at RSNA 2021 QMENTA executives will be available in booth 6633 during the conference. Schedule a meeting with...
We’re thrilled to be back at RSNA 2021, and it is very fitting that it is the first in-person event we have attended since the pandemic. QMENTA has been making tremendous progress on many radiology...
QMENTA’s Key Enhancements Are Critical Enablers of Success in Clinical Studies At QMENTA, we’re on a mission to empower breakthroughs that make brain diseases a thing of the past through our...
The QMENTA Medical Imaging AI Analyses Catalog and Disease Biomarker Packages are a first-in-industry solution that aggregates and curates industry standard and proprietary AI tools. ...
Women Around the World Recognized for Their Achievements. QMENTA wins Silver Startup of the Year....
Neuroimaging Software Solutions Provider QMENTA Announces Appointment of James Golando to Board of Directors...
Diffusion MRI (dMRI) is a vital imaging technique that provides great insight into the brain microstructure. Examining these microstructural properties of the brain can not only help enrich our...
A Landmark FDA Approval For Alzheimer’s Shakes Up Industry On June 7th, 2021, accelerated regulatory approval was granted for Alzheimer’s drug, Aduhelm (aducanumab), designed to slow cognitive...
Learning From the Pandemic. There has been a massive acceleration of digitally driven innovation recently and the biopharma industry is no exception. We've witnessed incredible speed in drug...